echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > National drug centralized procurement landing half a year 39 hospitals zero procurement!

    National drug centralized procurement landing half a year 39 hospitals zero procurement!

    • Last Update: 2020-08-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network August 4th , since the third batch of national drug tape procurement officially issued , the 56 varieties involved are in a hurry to prepare for the opening of tenders .
    so, the selected collection of varieties will be completed at that time procurement volume? The industry stretches its neck to watch all the wind and grass at the executive level of the collection.
    , a notice from the Hunan Provincial Health Insurance Bureau attracted the attention of the industry.
    the province informed the public of the implementation of the first batch of national collection of medicines in the first half of 2020: 25 selected drugs, Hunan Province plans to purchase a total of 23,192.54 million units (slices / grain), the total amount of planned procurement of 180.168 million yuan.
    as of June 30, the actual procurement of 199.673 million units (pieces, grains), the actual purchase amount of 32.23482 million yuan, the province's average procurement implementation progress of 86.07% (based on the number of procurement).
    it is worth noting that as of June 30, according to the statistics of 25 selected drugs, there are 39 county and county public medical institutions in the province have reported the amount of planned purchases but no procurement records of medical institutions.
    to put it bluntly, the actual procurement volume of these hospitals is 0.
    with the gradual start of the third batch of collection, the actual procurement situation in the provinces is also more and more attention to the industry.
    10 varieties completed the full-year procurement volume, Reinoplyd 765% after combing, "Pharmaceutical Economics" reporter saw that the first batch of national collection of drugs in Hunan Province since December 25, 2019 in the province,gifitini tablets, hydrosulphate tablets, atavestatine calcium tablets, fumachated di pivenone tablets and other 10 products completed the progress of more than 10 0percent.
    especially the high blood pressure drug Rynopri, the first half of the actual procurement completion progress reached 764.94 percent.
    according to the data released, the 10 selected drugs have completed the full-year planned purchase volume.
    at the same time, there are four selected drugs such as paroxetine agreed purchase volume completion schedule is less than 50%.
    from another dimension, in 14 cities and counties in Hunan Province, the total number of actual procurements has reached 100% of the total amount of planned procurement in Yandi City, Yongzhou City, Yiyang City, Huaihua City, Changsha City and Xiangtan City; The average progress of the
    is 86.07 percent, 39 hospitals have no procurement records, it is known that the co-ordination areas of Hunan Province in the first quarter of this year according to 30% of the purchase and sale contract amount completed the fund advance.
    the province to meet the advance payment of 4553.44 million yuan, the actual advance of 90,266.7 million yuan (including Yueyang and other places to co-ordinate the advance of the epidemic prevention and control funds).
    of which provincial direct should advance 1596.66 million yuan, the actual advance of 1596.66 million yuan.
    however, although most of the selected enterprises can actively overcome the impact of the outbreak of new crown pneumonia, effectively protect the supply of selected drugs, the average procurement implementation progress of 86.07 percent (based on the quantity purchased), but Atovastatin calcium tablets, reshuvastatin calcium tablets and other selected drugs due to production capacity lag, local basic reporting is not allowed, etc.
    the province's average distribution rate of 25 selected medicines was 96.77 percent.
    23 of these drugs had a distribution rate greater than 90%, the distribution rate of Imartinib capsules was 88.16%, and the distribution rate of attovastatin calcium tablets was 76.95%.
    it is worth noting that there are 39 agreed purchase volume but not procurement of county and county public medical institutions, such as Puyang County Hospital originally planned to purchase 181330 (pieces / grain / branch), the actual procurement volume is 0;
    reporters in the observation of this briefing form also noted that Huaihua Hongjiang District Maternal and Child Health Hospital originally planned to purchase 100 (slices / grain / branch), the actual procurement volume is also 0.
    although the notification did not provide further explanation of the reasons for the lack of procurement records in the 39 hospitals, it can be seen that the national collection still faces challenges when it actually lands. The three major problems of
    urgently need to be solved in Hunan Province are forming a normal supervision mechanism.
    focus on the establishment of relevant work desk accounts, grasp the actual situation, fulfill the interview, correspondence and other work measures and procedures, strengthen the management of agreements, for the second half of the implementation of relevant incentives and disciplinary measures to lay the foundation.
    they noticed three questions during the actual collection or raised the alarm for other provinces.
    is the problem of the timely settlement of drug payments.
    the above-mentioned circular sings that some medical institutions are in arrears with the purchase of medicines, especially at the grass-roots level.
    analysis mainly has the following reasons: hospitals subjectively did not seriously implement the policy requirements, some local medical insurance departments supervision and restraint is not enough, the role of discipline did not play.
    , in addition, to some extent affected by the outbreak of new coronal pneumonia.
    finally, some primary medical institutions need to go through the local accounting center, the settlement approval process is relatively complicated. The second
    is the uneven progress of drug collection.
    although affected by the outbreak of new crown pneumonia, medical institutions in-patient, outpatient business volume decreased significantly, affecting the procurement and use of selected drugs, but some medical institutions did not timely docking the selected drug distribution enterprises, the selected drugs were not included in the hospital procurement in a timely manner.
    some medical institutions reported the wrong amount, the actual demand and the agreed procurement volume gap is large, resulting in the statistical index is too low.
    also a common situation is that some medical institutions did not actively promote the clinical replacement of selected drugs as required, still a large number of procurement, the use of the same common name of non-selected varieties or pharmacological effects of similar varieties, resulting in the procurement of selected drugs, the use of slow progress.
    third, some medical institutions have not yet started procurement.
    the province has asked to start looking for the cause.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.